Olmetec and Head injury - a phase IV clinical study of FDA data

Summary:

Head injury is reported as a side effect among people who take Olmetec (olmesartan medoxomil), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Norvasc, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Head injury when taking Olmetec. It is created by eHealthMe based on reports of 7,816 people who have side effects when taking Olmetec from the FDA, and is updated regularly.

What is Olmetec?

Olmetec has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 7,904 Olmetec users. Check the latest studies of Olmetec.

What is Head injury?

Head injury is found to be associated with 2,629 drugs and 3,247 conditions by eHealthMe. Check the latest studies of Head injury.

On Jul, 14, 2026

7,816 people reported to have side effects when taking Olmetec.
Among them, 41 people (0.52%) have Head injury.

Among these 41 people:

How long have people been on Olmetec when they have Head injury? *

What is the gender of people who have Head injury when taking Olmetec? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Head injury when taking Olmetec? *

What are other drugs people take besides Olmetec? *

What are other side effects people have besides Head injury? *

Fall: 23 people, 56.10%
Urticaria (rash of round, red welts on the skin that itch intensely): 11 people, 26.83%
Cellulitis (infection under the skin): 11 people, 26.83%
Joint Pain: 9 people, 21.95%
Oedema Peripheral (superficial swelling): 8 people, 19.51%
Pain: 7 people, 17.07%
Blood Creatinine Increased: 7 people, 17.07%
Diarrhea: 7 people, 17.07%
Fever: 7 people, 17.07%
Chest Pain: 7 people, 17.07%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 26.83%
Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 14.63%
Cellulitis (infection under the skin): 6 people, 14.63%
Diarrhea: 6 people, 14.63%
Chest Pain: 6 people, 14.63%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 6 people, 14.63%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 6 people, 14.63%
Fever: 6 people, 14.63%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 12.20%
Insomnia (sleeplessness): 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Olmetec and have Head injury?

- Check whether Head injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olmetec:

Olmetec (7,904 reports)

Head injury treatments and more:

Head injury (160,560 reports)

Browse all side effects of Olmetec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Head injury:

Head injury (2,629 drugs)

Browse all the conditions that are associated with Head injury:

Head injury (3,247 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil (the active ingredients of Olmetec) and Olmetec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.